A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

Abroad (travel likely)RecruitingPHASE1

Conditions

Safety · Tolerability · Adult Growth Hormone Deficiency

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Third Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Dongyang LIU) · liudongyang@vip.sina.com · 18610966092

Study leads

Dongyang LIU, PHD
Principal Investigator
Peking University Third Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

Spinal Cord Injury · Safety · Clinical Trials

Abroad (travel likely)RecruitingPHASE1

Guangzhou, China

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Suzhou, China

Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE1

Linyi, China